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Ethosuximide completely  
suppressed epileptic negative myoclonus  
 in childhood localization-related epilepsy 
Ryuta Tanaka1, Tatsuyuki Ohto1, Takashi Saito1, Nobuaki Iwasaki1, 2, Ryo Sumazaki1 
We report two cases of localization-related 
epilepsy manifesting frequent brief atonia. The 
patients were assumed to have epileptic nega-
tive myoclonus (ENM), and were successfully 
treated with ethosuximide (ESM). Both exhib-
ited hemi-orofacial twitches during sleep, and 
interictal  electroencephalography  (EEG) 
showed paroxysms over the contralateral pos-
terior-temporal and centroparietal regions. In-
cessant atonia appeared at nine and 10 years of 
age accompanied by motor paresis. Ictal EEG 
showed  irregular  high-voltage  spike-waves 
predominantly over bilateral centroparietal re-
gions. Carbamazepine and zonisamide were 
ineffective in controlling, or even aggravated 
ENM. The addition of ESM resulted in imme-
diate and complete disappearance of ENM and 
partial motor seizures along with an improve-
ment of motor paresis. The first case was as-
sumed to have idiopathic etiology because of 
normal development before the onset of epi-
lepsy, while the second case was considered to 
have cryptogenic etiology based on a pre-
existing intellectual disability. Hence, we rec-
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ommend that ESM should be considered for 
the treatment of ENM that develops during the 
course  of  localization-related  epilepsy,  re-
gardless of  the etiology.  However,  further 
studies are still needed to evaluate the effects 
of ESM in the treatment of ENM. 
 
Introduction 
Epileptic negative myoclonus (ENM) is a 
characteristic seizure that occurs in various 
localization-related epilepsies (LREs). ENM 
represents a brief interruption of tonic muscle 
activity (<500 ms), time-locked to a spike on 
the  electroencephalogram  (EEG),  without 
evidence of an antecedent myoclonus [1]. The 
clinical manifestations include sudden drop-
ping of objects if the arm is involved, or fal-
ling to the floor if the leg is involved. Frequent 
ENM severely disrupt daily life activities and 
is often intractable. Here, we report two cases 
of LRE manifesting ENM that were success-
fully controlled by ethosuximide (ESM). ESM 
is thought to be effective for absence seizures 
but  ineffective  for  partial  seizures.  While 
some case reports have discussed ESM effi-
cacy for  LRE manifesting  several  seizure 
types including ENM, our two cases support 
previous findings of successful treatment of 
ENM associated with LRE by ESM. 
 
Case reports 
Case 1 
The patient was a nine-year-old girl with 
normal psychomotor development until the 
onset of epilepsy. Her family history was un-
remarkable and her past history included a 
febrile seizure at one year. At seven years of 
age, she had her first epileptic attack, a gener-
alized tonic seizure lasting several minutes. At 
that stage, an abnormality was detected by an 
electroencephalogram (EEG) and treatment 
with valproate (VPA) was initiated. Then, 
right or left facial twitches with licking and 
salivation were noted frequently during sleep. 
Sudden atonia on the right side of the body 
also occurred eventually. Treatment with car-
bamazepine  (CBZ)  and  zonisamide  (ZNS) 
aggravated brief atonia and were therefore 
replaced by clonazepam (CZP) after which 
some improvement was observed. At nine 
years of age, the occurrence of atonic attacks 
increased in frequency,  along with an in-
creased tendency to drop objects from the 
right hand and fall to the floor. One month 
later, she was referred to our hospital due to 
drowsiness and incessant atonia. Although she 
was right-handed, her grip was slightly weak 
on the right side. Brain magnetic resonance 
imaging (MRI) revealed no abnormality. An 
interictal EEG showed multifocal paroxysms 
predominantly over the left posterior-temporal 
and  centroparietal  (pT-C-P)  areas  during 
wakefulness (Fig. 1A) accompanied by gen-
eralized and almost continuous spike-waves 
during sleep (Fig. 1B). An ictal EEG revealed 
high-voltage irregular spike-waves predomi-
nantly over bilateral pT-C-P areas accompa-
nied by simultaneous dropping of her right 
arm, and sudden, brief loss of right deltoid 
electromyogram (EMG) (Fig. 1C). Continu-
ous intravenous midazolam (MDL) infused at 
0.1 mg/kg/hour decreased the frequency of the 
atonia to less than half of that observed ini-
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tially. However, atonia persisted even after a 
sufficient  period  of  treatment  with  MDL; 
subsequently ESM was added to the treatment 
regimen. This resulted in total disappearance 
of atonia and drowsiness within 24 hours of 
initiating the treatment. The patient has been 
seizure-free for two years since then, while on 
maintenance  treatment  with  16  mg/kg/day 
VPA, 0.03 mg/kg/day CZP, and 10 mg/kg/day 
ESM. Her right hand grip became normal, al-
though the Wechsler Intelligence Scale for 
Children-III (WISC-III) showed a borderline 
deficit at two months after the seizure-free 
period, with a verbal intelligence quotient (IQ) 
of 84, performance IQ of 64 and full scale IQ 
of 71. 
 
Case 2 
The patient was a ten-year-old girl with an 
unremarkable family history. She was delayed 
in speech, was hyperactive and excitable, with 
a full scale IQ of 49 by WISC-III at eight years 
of age. A blood examination and brain MRI 
revealed no abnormality. At six years of age, 
the first seizure occurred during sleep as a 
secondary generalized tonic-clonic convulsion. 
An abnormality was detected by EEG and 
VPA was started. Since the age of eight, sei-
zures increased progressively and usually oc-
curred soon after falling asleep. Seizures pre-
sented as twitching on the right side of the 
mouth with salivation and tonic contraction of 
the right upper limb. She was treated with an-
tiepileptic drugs such as CBZ and ZNS for the 
partial seizures, but with little clinical effect. 
An interictal  EEG revealed right  occipital 
paroxysms during wakefulness (Fig. 2A) and 
very frequent paroxysms over the left pT-C-P 
area during sleep (Fig. 2B). At 10 years of age, 
incessant brief atonia appeared in the trunk 
and the right arm, causing severe disruption of 
daily life activities. She was right-handed, but 
voluntary movement of the right arm was di-
minished because of the focal postural dysto-
nia (restricted to the right arm) that had not 
been noticed previously. An ictal EEG re-
vealed  irregular  high-voltage  spike-waves 
predominantly  over  bilateral  centroparietal 
areas simultaneous with repetitive atonic falls 
to the knee from a sitting position along with 
eyelid  twitches,  salivation,  and  decreased 
consciousness (Fig. 2C). Atonia disappeared 
completely within one week of adding ESM to 
the treatment regimen. Since then, she has 
been seizure-free for one year while on main-
tenance treatment with 20mg/kg/day VPA and 
10 mg/kg/day ESM. While dystonia has di-
minished, she requires risperidone for hyper-
activity and excitability that worsened since 
the occurrence of incessant atonia. 
 
Discussion 
In both cases, the atonia was confirmed to 
be ENM, which is brief interruption of tonic 
muscular activity corresponding to the spike-
wave  burst  on  EEG,  by simultaneous  re-
cording of an ictal EEG and surface EMG in 
Case 1, and by direct observation of atonia 
with an EEG recording in Case 2. 
ENM can be observed in a wide variety of 
idiopathic epilepsies such as benign childhood 
epilepsy  with  centrotemporal  spikes 
(BCECT);  symptomatic  epilepsies  such  as 
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mitochondrial diseases, birth anoxia and neu-
ronal migration disorders;  and cryptogenic 
conditions [2]. In this report, Case 1 was con-
sidered to have idiopathic etiology because 
normal development was observed before the 
onset of epilepsy, while Case 2 had a crypto-
genic etiology because of the preexisting in-
tellectual disability. 
A literature search identified a few reports 
of patients with LRE and ENM who had been 
successfully treated by ESM [3–7] (Table). 
The common features among our cases and 
the reported cases are as follows: 1) ENM oc-
curs between five and 10 years of age, i.e., the 
same period with the most frequent occur-
rence  of  absence  seizures;  2)  hemi-facial 
twitches are observed during sleep; 3) inter-
ictal paroxysms appear mainly over the con-
tralateral centroparietal and temporal regions, 
or rolandic area,  and are activated during 
sleep; and 4) an ictal EEG shows irregular 
high-voltage  spike-waves,  predominantly 
over the contralateral or bilateral centroparie-
tal regions. 
Aicardi et al. [8] distinguished an epileptic 
syndrome called “atypical benign partial epi-
lepsy (ABPE)”, which is similar to BCECT. 
ABPE manifests as generalized minor sei-
zures such as absence and atonic falls, and 
markedly activated paroxysms during sleep.   
“LRE with ENM” as described above has 
some overlapping features with ABPE, but 
differ in some aspects such as having crypto-
genic and symptomatic etiologies, and partial 
atonia instead of generalized minor seizures. 
Case 2 in this report, and most cases reported 
by Capovilla et al. [6], were treated with ESM 
and showed excellent improvement regardless 
of cryptogenic and symptomatic etiologies. 
It is possible that ENM and absence sei-
zure originate from the same brain region. 
Absence seizure was previously thought to 
originate from the subcortical or thalamic re-
gion and spread subsequently to the entire 
cortex, but a focal cortical origin has recently 
been suggested. In a study using rat model [9], 
spike-wave discharges originated consistently 
from the perioral region of the somatosensory 
cortex and propagated to the adjacent cortex 
and thalamus. In this regard, Oguni et al. [10] 
used the term “atonic absence seizures” for 
extensive ENM with loss of consciousness 
resulting  from expansion  of  epileptic  dis-
charges, which implies that ENM and absence 
seizure are part of the same continuum. In this 
report, Case 2 had repetitive atonia that in-
volved the trunk and was accompanied by loss 
of consciousness, which would correspond to 
“atonic absence seizures.” 
No partial motor seizures were observed 
after ESM was added to the treatment regimen 
in our cases. Two explanations can be pro-
posed: 1) ESM is effective for the treatment of 
partial motor seizures as well as ENM; and 2) 
ESM is only directly effective for ENM that 
has replaced partial motor seizure. The latter 
explanation seems to be more appropriate be-
cause partial motor seizure was rarely seen 
during incessant  ENM in both  our  cases. 
However, we also speculate that both cases 
may harbor a focal etiology; therefore, ESM 
also might counteract the pathway associated 
with the partial motor seizures. 
Both cases had facial twitches during sleep 
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Figure 1. EEG recordings of Case 1. 
A and B: Interictal recordings at nine years of age when increased episodes of brief atonia were observed.  
             Paroxysms mainly seen in the left pT-C-P area during wakefulness (A) are markedly activated during 
             sleep (B).  
C:          Ictal recording before ESM was prescribed during admission to our hospital at the age of nine. EEG was 
             recorded together with surface EMG on the right deltoid, in the standing position with arms actively   
             raised to horizontal position. Arrows indicate ENM: abrupt dropping of the right arm accompanied by 
             simultaneous paroxysms predominantly at bilateral pT-C-P areas.  
D:          Sleep recording after six months of treatment by ESM, when seizures were completely suppressed.  
             Note the marked reduction of paroxysmal discharge.  
EEG electrodes were placed according to a modification of 10-20 montage; C and P are the points divided in three 
between Fp and O on the vertex, whereas aT and pT are on the side of the head. Abbreviation: Lt; left, Rt; right. 
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Figure 2. EEG recordings of Case 2.  
A and B: Interictal recordings at the age of eight, before appearance of brief atonia. Paroxysms are mainly seen in 
             the right occipital area during wakefulness (A) and in the left pT-C-P area during sleep (B).  
C:          Ictal  recording at  10  years  of  age,  while  in  the  sitting position.  Repetitive  episodes  of  atonia 
             (arrowheads) with loss of consciousness followed by “atonic absence seizures” are seen.  
             Note that motion  artifacts increase as the patient falls down after the repetitive ENM. EEG electrodes were 
             placed as described in Figure 1. 
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 Table: A literature review of case reports describing localization-related epilepsy with epileptic negative myoclonus 
successfully treated by ethosuximide 
ENM; epileptic negative myoclonus, ESM; ethosuximide, SW; spike and wave, VPA; valproate, CBZ; carbamazepine, 
CLB; clobazam, ZNS; zonisamide, PB; phenobarbital, VGB; vigabatrin, BZP; benzodiazepine 
Past report Etiology 
Age at 
epilepsy 
onset 
Age at 
ENM  
onset 
Seizures  
besides ENM 
Body part 
affected by 
ENM 
Interictal  
paroxysms 
Ictal  
paroxysms of 
ENM 
Drugs besides 
ESM 
(→effect for 
ENM) 
Effect on 
epilepsy 
Kubota et 
al [3]. 1 
case 
Idiopathic 6 years  
4 months 
after onset 
of epilepsy 
Nocturnal left 
facial  
twitching, 
occasionally 
generalized 
Both arms to 
head 
Right C-T  
rolandic  
discharges 
Bilateral C-P 
SWs 
VPA, CBZ 
(→induce), 
 CLB 
（→partly 
effective） 
Completely 
free of ENM 
Oguni et 
al [4]. 6 
cases 
Idiopathic 2-8 years  
5-8 years 
of age 
Nocturnal 
focal 
(hemifacial to 
arm) motor 
seizures 
One arm to 
both arms, 
head, trunk 
SWs over  
C-P (-T) regions 
during awake, 
marked  
increasing  
during sleep 
Contralateral -
bilateral  
C-P(-T) SWs 
CBZ 
(→effective 
for none), 
VPA, ZNS, 
PB etc. 
Seizure-free 
in all cases  
Shirasaka 
et al [5]. 1 
case 
Idiopathic 9 years  
6 months 
after onset 
of epilepsy 
Generalized 
seizures  
during sleep 
Right arm 
SWs over right 
and left rolandic 
area, spreading 
during sleep 
SWs over left  
F-P region 
VPA, ZNS 
(→aggravate), 
CBZ 
(→aggravate) 
Seizure-free 
for 2 years 
under ESM 
monotherapy 
Capovilla 
et al [6]. 9 
cases 
Idiopathic, 
cryptogenic, 
symptomatic  
8 
months-
4 years  
3-12 years 
of age 
Partial  
seizures with 
secondary 
generaliza-
tion, spasms, 
atypical  
absences 
One limb to 
several parts 
of the body 
(Multi) Focal 
abnormalities 
with bilateral 
synchronization 
and continuous 
SWs  
during sleep 
Contralateral 
focal－diffuse 
(C-P dominant) 
SWs 
VPA, CBZ, 
PB, VGB, 
BZPs. 
Seizure-free 
in 5 cases, 
decreased 
more than 
75%  
in 4 cases 
Capovilla 
et al [7]. 2 
cases 
Idiopathic 3, 8 years  
3, 9 years 
of age 
Brief simple  
motor  
seizures at 
one leg or 
generalized 
seizures  
Unilateral 
leg and arm 
(with fecal 
inconti-
nence) 
Paroxysms over 
contralateral  
vertex regions 
increasing  
during sleep 
Spike(SW)s 
over  
contralateral  
F-C or Cz  
region 
VPA, CBZ, 
CLB 
Seizure-free 
for 1 year 
and 27 
months,  
respectively 
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but ENM occurred almost exclusively during 
posturing against gravity in the waking state. 
Hence, we propose that partial motor seizure 
and ENM originate from the same region 
closely related to the motor executive area in 
the cerebral cortex, and that the same abnor-
mal electrical discharge results in either posi-
tive or negative motor phenomenon deter-
mined by the degree of tonic muscular activ-
ity. Negative myoclonus can be evoked by 
electrical stimulation of the premotor cortex, 
primary  motor  cortex,  and  supplementary 
motor area necessary for the generation of 
proper motions [11]. Using magnetoencepha-
lography, one study [3] showed that ENM 
originated from the neck and orofacial region 
of the primary motor cortex. In our cases, 
motor paresis at the ENM-affected parts pro-
gressed transiently, highlighting a close rela-
tionship between ENM pathophysiology and 
motor execution. 
In both cases described here, the intellec-
tual  and  behavioral  problem  appeared  or 
worsened correlating with the occurrence of 
ENM, and persisted even after remission of 
seizures.  This outcome may be associated 
with the prolonged phase of epileptic activity. 
Hence early remission is advisable not only to 
lessen the seizure discomfort but also to re-
duce the likelihood of a long-lasting negative 
psychological impact. 
In the cases presented in this report, CBZ 
and ZNS, which are often used for LRE, were 
ineffective for the treatment of ENM or even 
aggravated it. Benzodiazepines such as CZP 
and MDL were partially effective. Similar 
therapeutic  responses  have  been  reported 
[4−6, 12]. ESM is effective in the pentylene-
tetrazol model, and specifically acts as a T-
type calcium channel  blocker  on thalamic 
neurons and related cortical assemblies [13–
15]. On the other hand, CBZ and ZNS are ef-
fective in the maximal electroshock model, 
and  act  on  the  sodium channel  [14,  15]. 
Therefore, different electrical pathophysiolo-
gies would cause different seizure types and 
invoke different drug responses. 
It is uncertain whether ESM is able to pre-
vent ENM before its onset; therefore, initiat-
ing treatment with ESM and discontinuing 
CBZ or ZNS soon after the appearance of 
ENM during the course of LRE is recom-
mended. 
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